.jpg)
- Expert opinion on therapeutic targets
-
影響因子：
4.13
-
I S S N：
1472-8222
-
出 版 社：
Informa Healthcare
-
出 版 地：
London
-
出版國(guó)家：
England
-
刊 期：
月刊
-
創(chuàng)刊時(shí)間：
2001
-
語(yǔ) 種：
英文
-
審稿周期：
偏慢,4-8周
-
中科院分區(qū)：
2
-
投稿命中率：
一般
-
國(guó)外數(shù)據(jù)庫(kù)收錄：
IM
-
中國(guó)收錄文章數(shù)：
28
-
5年影響因子：
3.732
-
研究領(lǐng)域：
藥物傳遞系統(tǒng)、藥物設(shè)計(jì)、藥物治療
-
官方鏈接：
http://informahealthcare.com/loi/ett
-
投稿須知：
http://informahealthcare.com/loi/ett
期刊介紹：
Expert Opinion on Therapeutic Targets is the premier journal dedicated to in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. Expert Opinion on Therapeutic Targets is a peer-reviewed journal providing evaluated and expert reviews of recent research identifying novel molecular drug targets. The journal provides an essential link between basic research on biological pathways and interactions, and the development of the drugs of tomorrow. It is distinguished from other publications by its high-quality authorship and expertly drafted articles which are structured to incorporate the author's own expertise on the subject. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, as well as many biotechnology companies.
